JPRN-UMIN000018385
Not yet recruiting
Phase 2
Phase II study of efficiency of peripheral blood stem cell harvest in POEMS syndrome patients with low-dose cyclophosphamide plus G-CSF - Phase II study of efficiency of peripheral blood stem cell harvest in POEMS syndrome patients with low-dose cyclophosphamide plus G-CSF
Chiba University Hospital Department of Hematology0 sites14 target enrollmentJuly 22, 2015
ConditionsPOEMS syndrome
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- POEMS syndrome
- Sponsor
- Chiba University Hospital Department of Hematology
- Enrollment
- 14
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients with plasma cells in CBC 2\) Pregnant or nursing women. Patients reuse to contraception during examination period 3\) Patients have active other malignant diseases including simultaneous cancer and disease free state within 5 years after treatment for other cancer except curable intramural cancer by local treatment. 4\) Patients with serious mental disorders 5\) Patients with HBs antigen\-positive 6\) Patients with HIV antibody\-positive 7\) Patients with a history of severe allergy to the drugs 8\) Patients with serious active infection 9\) Patients who are determined to be inappropriate for this study by physicians
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid CancersGastric CancerColorectal CancerPancreatic CancerSarcomaMesotheliomaNeuroendocrine TumorsSquamous Cell CancerMerkel Cell CarcinomaMismatch Repair DeficiencyMicrosatellite InstabilityNCT03935893Udai Kammula240
Recruiting
Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal MelanomaUveal NeoplasmsMelanoma, UvealNCT03467516Udai Kammula47
Active, not recruiting
Phase 2
A clinical trial of neoadjuvant taxane chemotherapy for women with locally advanced breast cancerocally advanced breast cancerLocally advanced breast cancerCancer - BreastACTRN12606000305527The Cancer Council Victoria40
Active, not recruiting
Phase 1
Phase II study to evaluate 68GaNOTA-Anti-MMR-VHH2 , a new tracer for positron emission tomography (PET/CT) of macrophages in oncological, hematological and cardiovascular diseases.EUCTR2020-002483-31-BEZ Brussel140
Active, not recruiting
Not Applicable
A phase II study to assess the efficacy of intravenous loading doses of Bondronat 6 mg on metastatic bone pain in patients with breast cancer and skeletal metastasesMetastatic bone disease related metastatic bone pain with breast as the primary site.EUCTR2006-001011-29-GRRoche (Hellas) S.A.